The Journal of Laboratory and Clinical Medicine January-June 2005: Vol 145 Index

3.6 MB·English

Index to Volume 145
Author Index*
A blood assays to optical platelet aggregation for monitoring rever-
Abdolell M (see Hard et al). 2005;145:47-54 sal of clopidogrel inhibition in elective surgery patients. 2005;
145:309-15
Ahmed N (see Gudehithlu et al). 2005;145:194-203
Altman NH (see Dominguez et al). 2005;145:65-71 (Review) Cristol J-P (see Maggiore et al). 2005;145:305-8
Aratake K (see Iwanaga et al). 2005;145:105-110 D
Aregawi D (see Glueck et al). 2005;145:72-82
Arends VL (see Tsai et al). 2005;145:323-27 Dahl R (see Kobak et al). 2005;145:247-62
Arija V (see Bertran et al). 2005;145:41-6 David S (see Maggiore et al). 2005;145:305-8
De Nitti C (see Maggiore et al). 2005;145:305-8
Arima K (see Iwanaga et al). 2005;145:105-110
Arnett DK (see Tsai et al). 2005;145:323-27 de Oliveira C, Colette C, Monnier L, Descomps B, Pares-Herbute N.
Arruda JAL (see Gudehithlu et al). 2005;145:194-203 Insulin alters nuclear factor-KB, peroxisome proliferator—acti-
vated receptor-y protein expression induced by glycated bovine
serum albumin in vascular smooth-muscle cells. 2005;145:144-50
Belcher JD (see Mahaseth et al). 2005;145:204-11 Descomps B (see de Oliveira et al). 2005;145:144-50
Bertran N, Camps J, Fernandez-Ballart J, Arija V, Ferre N, Tous M, Devereaux MW (see Kobak et al). 2005;145:247-62
Simo D, Murphy MM, Vilella E, Joven J. Diet, lifestyle are Devito R (see Marcellini et al). 2005;145:139-43
associated with serum C-reactive protein concentrations in a Di Bisceglie AM, Osmack P, Brunt EM. Chemoprevention of hepa-
population-based study. 2005;145:41-6 tocellular carcinoma: Use of tamoxifen in an animal model of
Bischof JC (see Mahaseth et al). 2005;145:204-11 hepatocarcinogenesis. 2005;145:134-8
Bowlin PR (see Mahaseth et al). 2005;145:204-11 Di Ciommo V (see Marcellini et al). 2005;145:139-43
Brunt EM (see Di Bisceglie et al). 2005;145:134-8 Di Serio F (see Specchia et al). 2005;145:212-20
Buquicchio C (see Specchia et al). 2005;145:212-20 Diette GB (see Hansel et al). 2005;145:263-74
Burhop KE (see Raat et al). 2005;145:21-32 Doctor RB (see Kobak et al). 2005;145:247-62
Buss N (see Solomon et al). 2005;145:275-83 Dominguez RA, Feaster DJ, Twiggs LB, Altman NH. Searching for
Cc an efficient institutional review board review model: Interrela-
tionship of trainee-investigators, funding, initial approval. 2005;
Callea F (see Marcellini et al). 2005;145:139-43 145:65-71 (Review)
Camps J (see Bertran et al). 2005;145:41-6 Dong N (see Zhang et al). 2005;145:98-104
Canaud B (see Maggiore et al). 2005;145:305-8 Doyle MP (see Raat et al). 2005;145:21-32
Carelli F (see Marcellini et al). 2005;145:139-43 Dunea G (see Gudehithlu et al). 2005;145:194-203
Carroll RC (see Craft et al). 2005;145:309-15 Dupuy AM (see Maggiore et al). 2005;145:305-8
Chandrashekhar Y. Multifunctional role of osteopontin in ventricular
remodeling. 2005;145:5-8 (Editorial)
Chang J-M (see Chiu et al). 2005;145:181-6 Eguchi K (see Iwanaga et al). 2005;145:105-110
Chang J-M (see Kuo et al). 2005;145:233-8 Eng H-L (see Pan et al). 2005;145:94-7
Chavez JJ (see Craft et al). 2005;145:309-15 Enjoji M (see Higashi et al). 2005;145:316-22
Chen H-C (see Chiu et al). 2005;145:181-6
F
Chen H-C (see Kuo et al). 2005;145:233-8
Chen W-J (see Pan et al). 2005;145:94-7 Feaster DJ (see Dominguez et al). 2005;145:65-71 (Review)
Chiu Y-W (see Kuo et al). 2005;145:233-8 Fernandez-Ballart J (see Bertran et al). 2005;145:41-6
Chiu Y-W, Kuo M-C, Kuo H-T, Chang J-M, Guh J-Y, Lai Y-H, Chen Ferre N (see Bertran et al). 2005;145:41-6
H-C. Alterations of glomerular, extracellular levels or glutathione Filice GA. Nocardiosis in persons with human immunodeficiency
peroxidase in patients and experimental rats with diabetic ne- virus infection, transplant recipients, large, geographically de-
phropathy. 2005;145:181-6
fined populations. 2005;145:156-62
Ciuffreda L (see Specchia et al). 2005;145:212-20 Formica M (see Maggiore et al). 2005;145:305-8
Clement JH (see Scholl et al). 2005;145:295-304 Fukushima M (see Higashi et al). 2005;145:316-22
Colette C (see de Oliveira et al). 2005;145:144-50
Comparcola D (see Marcellini et al). 2005;145:139-43 G
Comper WD (see Strong et al). 2005;145:239-46 Garber SL (see Gudehithlu et al). 2005;145:194-203
Consani C (see Maggiore et al). 2005;145:305-8 Georas SN (see Hansel et al). 2005;145:263-74
Cope LM (see Hansel et al). 2005;145:263-74 Gerling IC (see Solomon et al). 2005;145:275-83
Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Com- Ghosh AK, Ghosh K. Translating evidence-based information into
parison of modified Thrombelastograph, Plateletworks whole effective risk communication: Current challenges, opportunities.
2005;145:171-80 (Review)
*January, pp. 1-58; February, pp. 59-113; March, pp. 115-166; Ghosh K (see Ghosh and Ghosh). 2005;145:171-80 (Review)
April, pp. 167-223; May, pp. 225-284; June, pp. 285-342. Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P.
330
Index to Volume 145
Author Index*
A blood assays to optical platelet aggregation for monitoring rever-
Abdolell M (see Hard et al). 2005;145:47-54 sal of clopidogrel inhibition in elective surgery patients. 2005;
145:309-15
Ahmed N (see Gudehithlu et al). 2005;145:194-203
Altman NH (see Dominguez et al). 2005;145:65-71 (Review) Cristol J-P (see Maggiore et al). 2005;145:305-8
Aratake K (see Iwanaga et al). 2005;145:105-110 D
Aregawi D (see Glueck et al). 2005;145:72-82
Arends VL (see Tsai et al). 2005;145:323-27 Dahl R (see Kobak et al). 2005;145:247-62
Arija V (see Bertran et al). 2005;145:41-6 David S (see Maggiore et al). 2005;145:305-8
De Nitti C (see Maggiore et al). 2005;145:305-8
Arima K (see Iwanaga et al). 2005;145:105-110
Arnett DK (see Tsai et al). 2005;145:323-27 de Oliveira C, Colette C, Monnier L, Descomps B, Pares-Herbute N.
Arruda JAL (see Gudehithlu et al). 2005;145:194-203 Insulin alters nuclear factor-KB, peroxisome proliferator—acti-
vated receptor-y protein expression induced by glycated bovine
serum albumin in vascular smooth-muscle cells. 2005;145:144-50
Belcher JD (see Mahaseth et al). 2005;145:204-11 Descomps B (see de Oliveira et al). 2005;145:144-50
Bertran N, Camps J, Fernandez-Ballart J, Arija V, Ferre N, Tous M, Devereaux MW (see Kobak et al). 2005;145:247-62
Simo D, Murphy MM, Vilella E, Joven J. Diet, lifestyle are Devito R (see Marcellini et al). 2005;145:139-43
associated with serum C-reactive protein concentrations in a Di Bisceglie AM, Osmack P, Brunt EM. Chemoprevention of hepa-
population-based study. 2005;145:41-6 tocellular carcinoma: Use of tamoxifen in an animal model of
Bischof JC (see Mahaseth et al). 2005;145:204-11 hepatocarcinogenesis. 2005;145:134-8
Bowlin PR (see Mahaseth et al). 2005;145:204-11 Di Ciommo V (see Marcellini et al). 2005;145:139-43
Brunt EM (see Di Bisceglie et al). 2005;145:134-8 Di Serio F (see Specchia et al). 2005;145:212-20
Buquicchio C (see Specchia et al). 2005;145:212-20 Diette GB (see Hansel et al). 2005;145:263-74
Burhop KE (see Raat et al). 2005;145:21-32 Doctor RB (see Kobak et al). 2005;145:247-62
Buss N (see Solomon et al). 2005;145:275-83 Dominguez RA, Feaster DJ, Twiggs LB, Altman NH. Searching for
Cc an efficient institutional review board review model: Interrela-
tionship of trainee-investigators, funding, initial approval. 2005;
Callea F (see Marcellini et al). 2005;145:139-43 145:65-71 (Review)
Camps J (see Bertran et al). 2005;145:41-6 Dong N (see Zhang et al). 2005;145:98-104
Canaud B (see Maggiore et al). 2005;145:305-8 Doyle MP (see Raat et al). 2005;145:21-32
Carelli F (see Marcellini et al). 2005;145:139-43 Dunea G (see Gudehithlu et al). 2005;145:194-203
Carroll RC (see Craft et al). 2005;145:309-15 Dupuy AM (see Maggiore et al). 2005;145:305-8
Chandrashekhar Y. Multifunctional role of osteopontin in ventricular
remodeling. 2005;145:5-8 (Editorial)
Chang J-M (see Chiu et al). 2005;145:181-6 Eguchi K (see Iwanaga et al). 2005;145:105-110
Chang J-M (see Kuo et al). 2005;145:233-8 Eng H-L (see Pan et al). 2005;145:94-7
Chavez JJ (see Craft et al). 2005;145:309-15 Enjoji M (see Higashi et al). 2005;145:316-22
Chen H-C (see Chiu et al). 2005;145:181-6
F
Chen H-C (see Kuo et al). 2005;145:233-8
Chen W-J (see Pan et al). 2005;145:94-7 Feaster DJ (see Dominguez et al). 2005;145:65-71 (Review)
Chiu Y-W (see Kuo et al). 2005;145:233-8 Fernandez-Ballart J (see Bertran et al). 2005;145:41-6
Chiu Y-W, Kuo M-C, Kuo H-T, Chang J-M, Guh J-Y, Lai Y-H, Chen Ferre N (see Bertran et al). 2005;145:41-6
H-C. Alterations of glomerular, extracellular levels or glutathione Filice GA. Nocardiosis in persons with human immunodeficiency
peroxidase in patients and experimental rats with diabetic ne- virus infection, transplant recipients, large, geographically de-
phropathy. 2005;145:181-6
fined populations. 2005;145:156-62
Ciuffreda L (see Specchia et al). 2005;145:212-20 Formica M (see Maggiore et al). 2005;145:305-8
Clement JH (see Scholl et al). 2005;145:295-304 Fukushima M (see Higashi et al). 2005;145:316-22
Colette C (see de Oliveira et al). 2005;145:144-50
Comparcola D (see Marcellini et al). 2005;145:139-43 G
Comper WD (see Strong et al). 2005;145:239-46 Garber SL (see Gudehithlu et al). 2005;145:194-203
Consani C (see Maggiore et al). 2005;145:305-8 Georas SN (see Hansel et al). 2005;145:263-74
Cope LM (see Hansel et al). 2005;145:263-74 Gerling IC (see Solomon et al). 2005;145:275-83
Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Com- Ghosh AK, Ghosh K. Translating evidence-based information into
parison of modified Thrombelastograph, Plateletworks whole effective risk communication: Current challenges, opportunities.
2005;145:171-80 (Review)
*January, pp. 1-58; February, pp. 59-113; March, pp. 115-166; Ghosh K (see Ghosh and Ghosh). 2005;145:171-80 (Review)
April, pp. 167-223; May, pp. 225-284; June, pp. 285-342. Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P.
330
J Lab Clin Med
Volume 145, Number 6 Author Index 331
Idiopathic intracranial hypertension, polycystic-ovary syndrome,
thrombophilia. 2005; 145:72-82
Ida H (see Iwanaga et al). 2005;145:105-110
Goldenberg N (see Glueck et al). 2005;145:72-82 Imaizumi K (see Okamoto et al). 2005;145:88-93
Golnik KC (see Glueck et al). 2005;145:72-82 Ince C (see Raat et al). 2005;145:21-32
Gordon BR (see Rosenson et al). 2005;145:83-7
Irizarry RA (see Hansel et al). 2005;145:263-74
Greco G (see Specchia et al). 2005;145:212-20 Ishimitsu T (see Kamijo et al). 2005;145:125-33
Gross U (see Linke et al). 2005;145:187-93
Iwanaga N, Kamachi M, Aratake K, Izumi Y, Ida H, Tanaka F, Tamai
Gudehithlu KP, Ahmed N, Wu H, Litbarg NO, Garber SL, Arruda M, Arima K, Nakamura H, Origuchi T, Kawakami A, Eguchi K.
JAL, Dunea G, Singh AK. Antagonism of vascular endothelial Regulation of alternative splicing of caspase-2 through an intra-
growth factor results in microvessel attrition, disorganization of cellular signaling pathway in response to pro-apoptotic stimuli.
wound tissue. 2005;145:194-203 2005; 145:105-110
Guh J-Y (see Chiu et al). 2005;145:181-6 Iwasaki Y (see Okamoto et al). 2005:145:88-93
Guh J-Y (see Kuo et al). 2005;145:233-8 Izumi Y (see Iwanaga et al). 2005;145:105-110
Gumpricht E (see Kobak et al). 2005;145:247-62
J
Guo J (see Hansel et al). 2005;145:263-74
Jenkins GL, Sugarman J. The importance of cultural considerations in
H the promotion of ethical research with human biologic material.
2005;145:118-24 (Review)
Hammerschmidt DE. Claude Bernard (1813-1878). 2005;145:55-6
Joswig R (see Linke et al). 2005;145:187-93
(About the cover)
Joven J (see Bertran et al). 2005;145:41-6
Hammerschmidt DE. Kibuka’s umbilical cord. 2005;145:163 (About
the cover) K
Hammerschmidt DE. Polycystic ovaries. 2005;145:111 (About the Kamachi M (see Iwanaga et al). 2005;145:105-110
cover) Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu
Hammerschmidt DE. Thea sinensis-the common tea plant. 2005;145: T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T,
328 (About the cover) Mise N, Kimura K. Clinical evaluation of urinary excretion of
Hammerschmidt DE. This month in J Lab Clin Med. 2005;145:59-62 liver-type fatty acid—binding protein as a marker for the moni-
Hammerschmidt DE. This month in J Lab Clin Med. 2005;145: toring of chronic kidney disease: A multicenter trial. 2005;145:
115-17 125-33
Hammerschmidt DE. This month in J Lab Clin Med. 2005;145:1-4 Kawabe T (see Okamoto et al). 2005;145:88-93
Hammerschmidt DE. This month in J Lab Clin Med. 2005;145: Kawakami A (see Iwanaga et al). 2005;145:105-110
167-70 Kimura K (see Kamijo et al). 2005;145:125-33
Hammerschmidt DE. This month in J Lab Clin Med. 2005;145:225-7 Klein J (see Raat et al). 2005;145:21-32
Hammerschmidt DE. This month in JL ab Clin Med. 2005;145:285-8 Kobak GE, Dahl R, Devereaux MW, Gumpricht E, Traber M, Doctor
Hammerschmidt DE. Uroscopist-doctors visit. 2005;145:284 (About RB, Sokol RJ. Increased susceptibility of fat-laden Zucker-rat
the cover) hepatocytes to bile acid-induced oncotic necrosis: An in vitro
Hansel NN, Hilmer SC, Georas SN, Cope LM, Guo J, Irizarry RA, model of steatocholestasis. 2005;145:247-62
Diette GB. Oligonucleotide-microarray analysis of peripheral- Kobayashi N (see Higashi et al). 2005;145:316-22
blood lymphocytes in severe asthma. 2005;145:263-74 Kohjima M (see Higashi et al). 2005;145:316-22
Hanson NQ (see Tsai et al). 2005;145:323-27 Koren G (see Hard et al). 2005;145:47-54
Hara T (see Okamoto et al). 2005;145:88-93 Koten K (see Suezawa et al). 2005;145:33-40
Hard ML, Abdolell M, Robinson BH, Koren G. Gene-expression Kotoh K (see Higashi et al). 2005;145:316-22
Krause C (see Scholl et al). 2005;145:295-304
analysis after alcohol exposure in the developing mouse. 2005;
145:47-54 Kunert C (see Scholl et al). 2005;145:295-304
Kuo C-Y (see Pan et al). 2005;145:94-7
Hasegawa Y (see Okamoto et al). 2005;145:88-93
Hashimoto N (see Okamoto et al). 2005;145:88-93 Kuo H-T (see Chiu et al). 2005;145:181-6
Kuo H-T (see Kuo et al). 2005;145:233-8
Hayakawa H (see Kamijo et al). 2005;145:125-33
Kuo M-C (see Chiu et al). 2005;145:181-6
Hebbel RP (see Mahaseth et al). 2005;145:204-11
Kuo M-C, Kuo H-T, Chiu Y-W, Chang J-M, Guh J-Y, Lai Y-H, Chen
Hiebert LM, Wice SM, Ping T. Increased plasma anti-Xa activity,
H-C. Decreased synthesis of glomerular adrenomedullin in pa-
recovery of heparin from urine suggest absorption of orally ad-
tients with IgA nephrupathy. 2005;145:233-8
ministered unfractionated heparin in human subjects. 2005;145:
Kusachi S (see Suezawa et ai). 2005;145:33-40
151-5
Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, L
Kobayashi N, Nakamuta, Fukuoka, Okayama, Japan M. Epigal- Lai Y-H (see Chiu et al). 2005;145:181-6
locatechin-3-gallate, a green-tea polyphenol, suppresses Rho sig- Lai Y-H (see Kuo et al). 2005;145:233-8
naling in TWNT-4 human hepatic stellate cells. 2005;145:316-22 Lemley K. Proteinuria or peptiduria: Where’s the beef? 2005;145:
Hikawa A (see Kamijo et al). 2005;145:125-33 228-30 (Editorial)
Hilmer SC (see Hansel et al). 2005;145:263-74 Levine DM (see Rosenson et al). 2005;145:83-7
Hirata Y (see Kamijo et al). 2005;145:125-33 Linke RP, Joswig R, Murphy CL, Wang S, Zhou H, Gross U, Rocken
Hirohata S (see Suezawa et al). 2005;145:33-40 C, Westermark P, Weiss DT. Solomon, Martinsried A. Senile
Hoffken K (see Scholl et al). 2005; 145:295-304 seminal vesicle amyloid is derived from semenogelin I. 2005;
Hoke TR (see Tsai et al). 2005;145:323-27 145:187-93
Hsia CJC (see Mahaseth et al). 2005;145:204-11 Liso A (see Specchia et al). 2005;145:212-20
Huang, Kaohsiung H-Y (see Pan et al). 2005;145:94-7 Liso V (see Specchia et al). 2005;145:212-20
J Lab Clin Med
332 Author Index June 2005
Litbarg NO (see Gudehithlu et al). 2005;145:194-203 Pierach CA. Foie gras. 2005;145:231-2 (Editorial)
Liu J-F (see Raat et al). 2005;145:21-32 Ping T (see Hiebert et al). 2005;145:151-5
Loncarevic IF (see Scholl et al). 2005;145:295-304 Pozzato M (see Maggiore et al). 2005;145:305-8
M
Ma L (see Mahaseth et al). 2005;145:204-11
Raat NJH, Liu J-F, Doyle MP, Burhop KE, Klein J, Ince C. Effects
Maggiore U, Cristol J-P, Canaud B, Dupuy AM, Formica M, Pozzato
of recombinant-hemoglobin solutions rHb2.0, rHb1.1 on blood
M, Panichi V, Consani C, Metelli MR, Sereni L, De Nitti C,
pressure, intestinal blood flow, and gut oxygenation in a rat model
David S, Tetta C. Comparison of 3 automated assays for C-reac-
of hemorrhagic shock. 2005;145:21-32
tive protein in end-stage renal disease: Clinical, epidemiological
Robinson BH (see Hard et al). 2005;145:47-54
implications. 2005;145:305-8
Rocken C (see Linke et al). 2005;145:187-93
Mahaseth H, Vercellotti GM, Welch TE, Bowlin PR, Sonbol KM,
Rosenson RS, Tangney CC, Levine DM, Parker TS, Gordon BR.
Hsia CJC, Ma L, Bischof JC, Hebbel RP, Belcher JD. Polyni-
Association between reduced low density lipoprotein oxidation,
troxyl albumin inhibits inflammation, vasoocclusion in transgenic
inhibition of monocyte chemoattractant protein-1 production in
sickle mice. 2005;145:204-11
statin-treated subjects. 2005;145:83-7
Majumdar G (see Solomon et al). 2005;145:275-83
Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D,
S
Sartorelli MR, Carelli F, Nobili V. Treatment of Wilson’s disease
with zinc from the time of diagnosis in pediatric patients: A Sartorelli MR (see Marcellini et al). 2005;145:139-43
single-hospital, 10-year follow-up study. 2005;145:139-43 Satin DJ. More realism about informed consent. 2005;145:292-4
Mestice A (see Specchia et al). 2005;145:212-20 (Editorial)
Metelli MR (see Maggiore et al). 2005;145:305-8 Sayer HG (see Scholl et al). 2005;145:295-304
Miller FG (see Schechter and Miller). 2005;145:9-11 (Editorial) Schechter AN, Miller FG. To publish or not to publish? 2005;145:
Mise N (see Kamijo et al). 2005;145:125-33 9-11 (Editorial)
Miyoshi T (see Suezawa et al). 2005;145:33-40 Schneider CE. Some realism about informed consent. 2005;145:
Monnier L (see de Oliveira et al). 2005;145:144-50, 289-91 (Editorial)
Monnier S (see Solomon et al). 2005;145:275-83 Scholl S, Krause C, Loncarevic IF, Miiller R, Kunert C, Wedding U,
Muenchen RA (see Craft et al). 2005;145:309-15 Sayer HG, Clement JH, H6éffken K. Specific detection of FIt3
Miiller R (see Scholl et al). 2005;145:295-304 point mutations by highly sensitive real-time polymerase chain
Murakami T (see Suezawa et al). 2005;145:33-40 reaction in acute myeloid leukemia. 2005;145:295-304
Murphy CL (see Linke et al). 2005;145:187-93 Schteingart DE. The 50th anniversary of the identification of primary
Murphy MM (see Bertran et al). 2005;145:41-6 aldosteronism: A retrospective of the work of Jerome W. Conn.
N 2005;145:12-16 (Editorial)
Sereni L (see Maggiore et al). 2005;145:305-8
Nakamura H (see Iwanaga et al). 2005;145:105-110 Shimokata K (see Okamoto et al). 2005;145:88-93
Nakamura K (see Suezawa et al). 2005;145:33-40
Shiratori Y (see Suezawa et al). 2005;145:33-40
Nakamuta, Fukuoka, Okayama, Japan M (see Higashi et al). 2005;
Shull J (see Solomon et al). 2005;145:275-83
145:316-22
Sieve L (see Glueck et al). 2005;145:72-82
Nobili V (see Marcellini et al). 2005;145:139-43
Simo D (see Bertran et al). 2005;145:41-6
Numabe A (see Kamijo et al). 2005;145:125-33 Singh AK (see Gudehithlu et al). 2005;145:194-203
oO Snider CC (see Craft et al). 2005;145:309-15
Sokol RJ (see Kobak et al). 2005;145:247-62
Ohta S (see Higashi et al). 2005;145:316-22
Solomon, Martinsried A (see Linke et al). 2005;145:187-93
Okamoto M, Kawabe T, Iwasaki Y, Hara T, Hashimoto N, Imaizumi
Solomon SS, Buss N, Shull J, Monnier S, Majumdar G, Wu J,
K, Hasegawa Y, Shimokata K. Evaluation of interferon-y, inter-
Gerling IC. Proteome of H-411E (liver) cells exposed to insulin,
feron-y-inducing cytokines, interferon-y—inducible chemokines
tumor necrosis factor-a: Analysis of proteins involved in insulin
in tuberculous pleural effusions. 2005; 145:88-93
resistance. 2005; 145:275-83
Oleson KA. Role of the industry sponsor: Protection of human
subjects in early device-application studies. 2005;145:17-20 (Re- Sonbol KM (see Mahaseth et al). 2005;145:204-11
view) Specchia G, Buquicchio C, Pansini N, Di Serio F, Liso V, Pastore D,
Ordovas JM (see Tsai et al). 2005;145:323-27 Greco G, Ciuffreda L, Mestice A, Liso A. Monitoring of cardiac
Origuchi T (see Iwanaga et al). 2005;145:105-110 function on the basis of serum troponin I levels in patients with
Osicka TM (see Strong et al). 2005;145:239-46 acute leukemia treated with anthracyclines. 2005;145:212-20
Osmack P (see Di Bisceglie et al). 2005;145:134-8 Straka RJ (see Tsai et al). 2005;145:323-27
Strong KJ, Osicka TM, Comper WD. Urinary-peptide excretion by
Pp
patients with, volunteers without diabetes. 2005;145:239-46
Pan L-L, Eng H-L, Kuo C-Y, Chen W-J, Huang, Kaohsiung H-Y. Suezawa C, Kusachi S, Murakami T, Toeda K, Hirohata S, Nakamura
Usefulness of brilliant cresy] blue staining as an auxiliary method K, Yamamoto K, Koten K, Miyoshi T, Shiratori Y. Time-depen-
of screening for a-thalassemia. 2005;145:94-7 dent changes in plasma osteopontin levels in patients with ante-
Panichi V (see Maggiore et al). 2005;145:305-8 rior-wall acute myocardial infarction after successful reperfusion:
Pansini N (see Specchia et al). 2005;145:212-20 Correlation with left-ventricular volume, function. 2005;145:
Pares-Herbute N (see de Oliveira et al). 2005;145:144-50 33-40
Parker TS (see Rosenson et al). 2005;145:83-7 Sugarman J (see Jenkins and Sugarman). 2005;145:118-24 (Review)
Pastore D (see Specchia et al). 2005;145:212-20 Sugaya T (see Kamijo et al). 2005;145:125-33
Peacock JM (see Tsai et al). 2005;145:323-27 Sugimoto T (see Kamijo et al). 2005;145:125-33
J Lab Clin Med
Volume 145, Number 6 Author Index 333
T Wang S (see Linke et al). 2005;145:187-93
Tabei F (see Kamijo et al). 2005;145:125-33 Wedding U (see Scholl et al). 2005;145:295-304
Takagi M (see Kamijo et al). 2005;145:125-33 Weiss DT (see Linke et al). 2005;145:187-93
Tamai M (see Iwanaga et al). 2005;145:105-110 Weksler BB. Linking thrombophilia, idiopathic intracranial hyper-
Tanaka F (see Iwanaga et al). 2005;145:105-110 tension. 2005;145:63-4 (Editorial)
Tangney CC (see Rosenson et al). 2005;145:83-7 Welch TE (see Mahaseth et al). 2005;145:204-11
Tetta C (see Maggiore et al). 2005;145:305-8 Westermark P (see Linke et al). 2005;145:187-93
Toeda K (see Suezawa et al). 2005;145:33-40 Wice SM (see Hiebert et al). 2005;145:151-5
Tous M (see Bertran et al). 2005;145:41-6 Wu H (see Gudehithlu et al). 2005;145:194-203
Traber M (see Kobak et al). 2005;145:247-62 Wu J (see Solomon et al). 2005;145:275-83
Tsai MY, Hanson NQ, Straka RJ, Hoke TR, Ordovas JM, Peacock
JM, Arends VL, Arnett DK. Effect of influenza vaccine on Y
markers of inflammation and lipid profile: National Heart, Lung, Yamamoto K (see Suezawa et al). 2005;145:33-40
and Blood Institute Genetics of Lipid Lowering Drugs and Diet Yamanouchi M (see Kamijo et al). 2005;145:125-33
Network Study. 2005;145:323-27 Ye L (see Zhang et al). 2005;145:98-104
Twiggs LB (see Dominguez et al). 2005;145:65-71 (Review)
You J (see Zhang et al). 2005;145:98-104
Vv
Zz
Vercellotti GM (see Mahaseth et al). 2005;145:204-11
Zhang H (see Zhang et al). 2005;145:98-104
Vilella E (see Bertran et al). 2005;145:41-6
Zhang X, Dong N, Zhang H, You J, Wang H, Ye L. Effects of
WwW hepatitis B virus X protein on human telomerase reverse tran-
Wang H (see Zhang et al). 2005;145:98-104 scriptase expression, activity in hepatoma cells. 2005;145:98-104
Wang P (see Glueck et al). 2005;145:72-82 Zhou H (see Linke et al). 2005;145:187-93
Index to Volume 145
subject Index*
A This month in J Lab Clin Med (Hammerschmidt). 2005;145:
167-70
Acquired immunodeficiency syndrome
Nocardiosis in persons with human immunodeficiency virus in- Anthracyclines
fection, transplant recipients, and large, geographically de- Monitoring of cardiac function on the basis of serum troponin I
fined populations (Filice). 2005; 145:156-62 levels in patients with acute leukemia treated with anthracy-
This month in J Lab Clin Med (Hammerschmidt). 2005;145: clines (Specchia et al). 2005;145:212-20
115-7 This month in J Lab Clin Med (Hammerschmidt). 2005;145:
167-70
Acute lymphoid leukemia; see Leukemia, lymphocytic
Acute myeloid leukemia; see Leukemia, myeloid Anti factor-Xa
Increased plasma anti-Xa activity and recovery of heparin from
Administration, oral
urine suggest absorption of orally administered unfractionated
Increased p'asma anti-Xa activity and recovery of heparin from
heparin in human subjects (Hiebert et al). 2005;145:151-5
urine suggest absorption of orally administered unfractionated
heparin in human subjects (Hiebert et al). 2005;145:151-5 Anti-inflammatory agents, non-steroidal
Comparison of modified Thromboelastograph and Plateletworks
Adrenomedullin
whole blood assays to optical platelet aggregation for moni-
Decreased synthesis of glomeruiar adrenomedullin in patients
with IgA nephropathy (Kuo et al). 2005;145:233-8 toring reversal of clopidogrel inhibition in elective surgery
This month in J Lab Clin Med (Hammerschmidt). 2005;145: patients (Craft et al). 2005;145:309-15
225-7 Antigens, viral
Advanced glycation end products; see Glycosylation end products, This month in J Lab Clin Med (Hammerschmidt). 2005;145:
advanced 59-62
Albumins; see also Polynitroxyl-albumin Apoptosis
Proteinuria or peptiduria: Where’s the beef? (Lemley). 2005;145: Regulation of alternative splicing of caspase-2 through an intra-
228-30 (Editorial) cellular signaling pathway in response to pro-apoptotic stim-
Urinary-peptide excretion by patients with and volunteers without uli (Iwanaga et al). 2005;145:105-10
diabetes (Strong et al). 2005;145:239-46 This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Albuminuria 59-62
Proteinuria or peptiduria: Where’s the beef? (Lemley). 2005;145: Asthma
228-30 (Editorial) Oligonucleotide-microarray analysis of peripheral-blood lympho-
This month in J Lab Clin Med (Hammerschmidt). 2005;145: cytes in severe asthma (Hansel et al). 2005;145:263-74
225-7
Urinary-peptide excretion by patients with and volunteers without
diabetes (Strong et al). 2005;145:239-46
Alcohol; see Ethanol Bernard, Claude
Alternative splicing Claude Bernard (1813-1878) (Hammerschmidt). 2005;145:55-6
Regulation of alternative splicing of caspase-2 through an intra- (About the cover)
cellular signaling pathway in response to pro-apoptotic stim- Bile acid
uli (Iwanaga et al). 2005;145:105-10 Increased susceptibility of fat-laden Zucker-rat hepatocytes to
This month in J Lab Clin Med (Hammerschmidt). 2005;145: bile acid-induced oncotic necrosis: An in vitro model of
59-62 steatocholestasis (Kobak et al). 2005;145:247-62
AM; see Adrenomedullin Binding sites
Amyloid This month in J Lab Clin Med (Hammerschmidt). 2005;145:1-4
Senile seminal vesicle amyloid is derived from semenogelin I Biological markers
(Linke et al). 2005;145:187-93
Clinical evaluation of urinary excretion of liver-type fatty acid-
Amyloidosis binding protein as a marker for the monitoring of chronic
Senile seminal vesicle amyloid is derived from semenogelin I kidney disease: A multicenter trial (Kamijo et al). 2005;145:
(Linke et al). 2005;145:187-93 125-33 y
Anemia, sickle cell Effect of influenza vaccine on markers of inflammation lipid -
Polynitroxy! albumin inhibits inflammation and vasoocclusion in profile: National Heart, Lung, and Blood Institute Genetics of
transgenic sickle mice (Mahaseth et al). 2005;145:204-11 Lipid Lowering Drugs and Diet Network Study (Tsai et al).
2005; 145:323-7
Evaluation of interferon-y, interferon-y-inducing cytokines, and
*January, pp. 1-58; February, pp. 59-113; March, pp. 115-166; April, interferon-y-inducible chemokines in tuberculous pleural ef-
pp. 167-223; May, pp. 225-284; June, pp. 285-342. fusions (Okamoto et al). 2005;145:88-93
334
J Lab Clin Med
Volume 145, Number 6 Subject Index 335
Biomedical! research Caspase-2
The importance of cultural considerations in the promotion of Regulation of alternative splicing of caspase-2 through an intra-
ethical research with human biologic material (Jenkins and cellular signaling pathway in response to pro-apoptotic stim-
Sugarman). 2005;145:118-24 (Review) uli (Iwanaga et al). 2005;145:105-10
Blood pressure CD4-positive T-lymphocytes
Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1
Oligonucleotide-microarray analysis of peripheral-blood lympho-
on blood pressure, intestinal blood flow, and gut oxygenation
cytes in severe asthma (Hansel et al). 2005;145:263-74
in a rat model of hemorrhagic shock (Raat et al). 2005;145:
21-32 Ceramides
To publish or not to publish? (Schechter and Miller). 2005;145: Regulation of alternative splicing of caspase-2 through an intra-
9-11 (Editorial) cellular signaling pathway in response to pro-apoptotic stim-
To publish or not to publish (Winslow) (Letter); (Hammer- uli (Iwanaga et al). 2005;145:105-10
schmidt) (Reply). 2005;145:221-2 Chemokines, CXC
Blood substitutes Evaluation of interferon-y, interferon-y-inducing cytokines, and
To publish or not to publish (Winslow) (Letter); (Hammer- interferon-y-inducible chemokines in tuberculous pleural ef-
schmidt) (Reply). 2005;145:221-2 fusions (Okamoto et al). 2005;145:88-93
Blood vessels Chemoprevention
Antagonism of vascular endothelial growth factor results in mi- Chemoprevention of hepatocellular carcinoma: Use of tamoxifen
crovessel attrition and disorganization of wound tissue (Gu- in an animal model of hepatocarcinogenesis (Di Bisceglie et
dehithlu et al). 2005;145:194-203 al). 2005; 145:134-8
Bone marrow transplantation This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Nocardiosis in persons with human immunodeficiency virus in- 115-7
fection, transplant recipients, and large, geographically de-
Chemotherapy
fined populations (Filice). 2005; 145:156-62
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Brain 167-70
Gene-expression analysis after alcohol exposure in the develop-
Child
ing mouse (Hard et al). 2005;145:47-54
Treatment of Wilson’s disease with zinc from the time of diag-
Brilliant cresyl blue
nosis in pediatric patients: A single-hospital, 10-year fol-
Usefulness of brilliant cresyl blue staining as an auxiliary method
low-up study (Marcellini et al). 2005;145:139-43
of screening for a-thalassemia (Pan et al). 2005;145:94-7
13-Cis retinoic acid; see [sotretinoin
Cc Clinical ethics; see Ethics, clinical
Clopidogrel
C-reactive protein
Comparison of modified Thromboelastograph and Plateletworks
Comparison of 3 automated assays for C-reactive protein in
whole blood assays to optical platelet aggregation for moni-
end-stage renal disease: Clinical and epidemiological impli-
cations (Maggiore et al). 2005;145:305-8 toring reversal of clopidogrel inhibition in elective surgery
patients (Craft et al). 2005;145:309-15
Diet and lifestyle are associated with serum C-reactive protein
concentrations in a population-based study (Bertran et al). Communication
2005;145:41-6 Translating evidence-based information into effective risk com-
Effect of influenza vaccine on markers of inflammation lipid munication: Current challenges and opportunities (Ghosh and
profile: National Heart, Lung, and Blood Institute Genetics of Ghosh). 2005;.145:171-80 (Review)
Lipid Lowering Drugs and Diet Network Study (Tsai et al). Conn, Jerome W.
2005; 145:323-7
The 50th anniversary of the identification of primary aldosteron-
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
ism: A retrospective of the work of Jerome W. Conn (Schtein-
285-8
gart). 2005;145:12-16 (Editorial)
Carcinogenesis This month in J Lab Clin Med (Hammerschmidt). 2005;145:1-4
Chemoprevention of hepatocellular carcinoma: Use of tamoxifen
Culture
in an animal model of hepatocarcinogenesis (Di Bisceglie et
al). 2005;145:134-8 The importance of cultural considerations in the promotion of
ethical research with human biologic material (Jenkins and
Cardiac function
Sugarman). 2005;145:118-24 (Review)
Monitoring of cardiac function on the basis of serum troponin I
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
levels in patients with acute leukemia treated with anthracy-
115-7
clines (Specchia et al). 2005;145:212-20
Cardiac volume Cycloheximide
Time-dependent changes in plasma osteopontin levels in patients Regulation of alternative splicing of caspase-2 through an intra-
with anterior-wall acute myocardial infarction after successful cellular signaling pathway in response to pro-apoptotic stim-
reperfusion: Correlation with left-ventricular volume and uli (Iwanaga et al). 2005;145:105-10
function (Suezawa et al). 2005;145:33-40 Cytokines
Cardiotoxicity Evaluation of interferon-y, interferon-y-inducing cytokines, and
This month in J Lab Clin Med (Hammerschmidt). 2005;145: interferon-y-inducible chemokines in tuberculous pleural ef-
167-70 fusions (Okamoto et al). 2005;145:88-93
J Lab Clin Med
336 Subject Index June 2005
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
285-8
Device approval
Role of the industry sponsor: Protection of human subjects in Equipment and supplies
early device-application studies (Oleson). 2005;145:17-20 Role of the industry sponsor: Protection of human subjects in
(Review) early device-application studies (Oleson). 2005;145:17-20
Diabetes mellitus (Review)
Proteinuria or peptiduria: Where’s the beef? (Lemley). 2005;145: Estrogens
228-30 (Editorial) Chemoprevention of hepatocellular carcinoma: Use of tamoxifen
Urinary-peptide excretion by patients with and volunteers without in an animal model of hepatocarcinogenesis (Di Bisceglie et
diabetes (Strong et al). 2005;145:239-46 al). 2005; 145:134-8
Diabetic glomerulosclerosis; see Diabetic nephropathies Ethanol
Diabetic nephropathies Gene-expression analysis after alcohol exposure in the develop-
Alterations of glomerular and extracellular levels of glutathione ing mouse (Hard et al). 2005;145:47-54
peroxidase in patients and experimental rats with diabetic Ethics, clinical
nephropathy (Chiu et al). 2005;145:181-6 Some realism about informed consent (Schneider). 2005;145:
Diabetic injury to the kidney (Hammerschmidt). 2005;145:223 289-91 (Editorial)
(About the cover) This month in J Lab Clin Med (Hammerschmidt). 2005;145:
This month in J Lab Clin Med (Hammerschmidt). 2005;145: 285-8
167-70 Ethics, research
Diagnostic techniques The importance of cultural considerations in the promotion of
Usefulness of brilliant cresyl blue staining as an auxiliary method ethical research with human biologic material (Jenkins and
of screening for a-thalassemia (Pan et al). 2005;145:94-7 Sugarman). 2005;145:118-24 (Review)
Diet Some realism about informed consent (Schneider). 2005;145:
Diet and lifestyle are associated with serum C-reactive protein 289-91 (Editorial)
concentrations in a population-based study (Bertran et al). This month in J Lab Clin Med (Hammerschmidt). 2005;145:
2005;145:41-6 115-7, 285-8
Disease progression Etoposide
Clinical evaluation of urinary excretion of liver-type fatty acid- Regulation of alternative splicing of caspase-2 through an intra-
binding protein as a marker for the monitoring of chronic cellular signaling pathway in response to pro-apoptotic stim-
kidney disease: A multicenter trial (Kamijo et al). 2005;145: uli (Iwanaga et al). 2005;145:105-10
125-33
Evidence-based medicine
Drug monitoring This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Comparison of modified Thromboelastograph and Plateletworks 167-70
whole blood assays to optical platelet aggregation for moni- Translating evidence-based information into effective risk com-
toring reversal of clopidogrel inhibition in elective surgery ‘munication: Current challenges and opportunities (Ghosh and
patients (Craft et al). 2005;145:309-15 Ghosh). 2005;145:171-80 (Review)
E
F
Editorials
Foie gras (Pierach). 2005;145:231-2 Fatty acid-binding proteins, liver-type
Linking thrombophilia and idiopathic intracranial hypertension Clinical evaluation of urinary excretion of liver-type fatty acid-
(Weksler). 2005;145:63-4 binding protein as a marker for the monitoring of chronic
More realism about informed consent (Satin). 2005;145:292-4 kidney disease: A multicenter trial (Kamijo et al). 2005;145:
Multifunctional role of osteopontin in ventricular remodeling 125-33
(Chandrashekhar). 2005;145:5-8 (Editorial) Fatty liver
Proteinuria or peptiduria: Where’s the beef? (Lemley). 2005;145: Foie gras (Pierach). 2005;145:231-2 (Editorial)
228-30
Increased susceptibility of fat-laden Zucker-rat hepatocytes to
To publish or not to publish? (Schechter and Miller). 2005;145:
bile acid-induced oncotic necrosis: An in vitro model of
9-11 (Editorial) steatocholestasis (Kobak et al). 2005;145:247-62
Some realism about informed consent (Schneider). 2005;145:
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
289-91 225-7
The 50th anniversary of the identification of primary aldosteron-
Fetal alcohol syndrome
ism: A retrospective of the work of Jerome W. Conn (Schtein-
gart). 2005;145:12-16 (Editorial) Gene-expression analysis after alcohol exposure in the develop-
ing mouse (Hard et al). 2005;145:47-54
End-stage renal disease
Comparison of 3 automated assays for C-reactive protein in Fetal development
end-stage renal disease: Clinical and epidemiological impli- Gene-expression analysis after alcohol exposure in the develop-
cations (Maggiore et al). 2005;145:305-8 ing mouse (Hard et al). 2005;145:47-54
Epigallocatechin-3-gallate Fibrinolysis
Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Idiopathic intracranial hypertension, polycystic-ovary syndrome,
Rho signaling in TWNT-4 human hepatic stellate cells (Hi- and thrombophilia (Glueck et al). 2005;145:72-82
gashi et al). 2005;145:316-22 FIt3 receptor tyrosine kinase; see FMS-like tyrosine kinase 3
J Lab Clin Med
Volume 145, Number 6 Subject Index 337
FMS-like tyrosine kinase 3 Hemoglobin H
Specific detection of FIt3 point mutations by highly sensitive Usefulness of brilliant cresyl blue staining as an auxiliary method
real-time polymerase chain reaction in acute myeloid leuke- of screening for a-thalassemia (Pan et al). 2005;145:94-7
mia (Scholl et al). 2005;145:295-304
Hemoglobins
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1
285-8
on blood pressure, intestinal blood flow, and gut oxygenation
Follow-up studies in a rat model of hemorrhagic shock (Raat et al). 2005;145:
Treatment of Wilson’s disease with zinc from the time of diag- 21-32
nosis in pediatric patients: A single-hospital, 10-year fol-
To publish or not to publish? (Schechter and Miller). 2005;145:
low-up study (Marcellini et al). 2005;145:139-43
9-11 (Editorial)
Free radical scavengers This month in J Lab Clin Med (Hammerschmidt). 2005;145:1-4
Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1
Hemorrhagic shock
on blood pressure, intestinal blood flow, and gut oxygenation
Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1
in a rat model of hemorrhagic shock (Raat et al). 2005;145:
21-32 on blood pressure, intestinal blood flow, and gut oxygenation
To publish or not to publish? (Schechter and Miller). 2005;145: in a rat model of hemorrhagic shock (Raat et al). 2005;145:
21-32
9-11 (Editorial)
This month in J Lab Clin Med (Hammerschmidt). 2005; 145: 1-4 To publish or not to publish? (Schechter and Miller). 2005;145:
9-11 (Editorial)
G To publish or not to publish (Winslow) (Letter); (Hammer-
schmidt) (Reply). 2005; 145:221-2
Gene expression profiling
Gene-expression analysis after alcohol exposure in the develop- Heparin
ing mouse (Hard et al). 2005;145:47-54 Increased plasma anti-Xa activity and recovery of heparin from
Oligonucleotide-microarray analysis of peripheral-blood lympho- urine suggest absorption of orally administered unfractionated
cytes in severe asthma (Hansel et al). 2005;145:263-74 heparin in human subjects (Hiebert et al). 2005;145:151-5
Genetic translocation; see Translocation, genetic Hepatic stellate cells
Glomerulonephritis, IgA Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses
Decreased synthesis of glomerular adrenomedullin in patients Rho signaling in TWNT-4 human hepatic stellate cells (Hi-
with IgA nephropathy (Kuo et al). 2005;145:233-8 gashi et al). 2005;145:316-22
This month in J Lab Clin Med (Hammerschmidt). 2005;145: This month in J Lab Clin Med (Hammerschmidt). 2005;145:
225-7 285-8
Glutathione peroxidase Hepatitis B antigens
Alterations of glomerular and extracellular levels of glutathione Effects of hepatitis B virus X protein on human telomerase
peroxidase in patients and experimental rats with diabetic reverse transcriptase expression and activity in hepatoma cells
nephropathy (Chiu et al). 2005;145:181-6 (Zhang et al). 2005;145:98-104
Glycosylation end products, advanced Hepatitis B virus X protein; see Hepatitis B antigens
Insulin alters nuclear factor-kB and peroxisome proliferator-ac-
Hepatocellular carcinoma
tivated receptor-y protein expression induced by glycated
Chemoprevention of hepatocellular carcinoma: Use of tamoxifen
bovine serum albumin in vascular smooth-muscle cells (De
in an animal model of hepatocarcinogenesis (Di Bisceglie et
Oliveira et al). 2005;145:144-50
al). 2005;145:134-8
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
115-7 Effects of hepatitis B virus X protein on human telomerase
reverse transcriptase expression and activity in hepatoma cells
GPX; see Glutathione peroxidase
(Zhang et al). 2005;145:98-104
Granuloma
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Antagonism of vascular endothelial growth factor results in mi- 115-7
crovessel attrition and disorganization of wound tissue (Gu-
dehithlu et al). 2005;145:194-203 Hepatocytes
Increased susceptibility of fat-laden Zucker-rat hepatocytes to
Green tea
bile acid-induced oncotic necrosis: An in vitro model of
Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses
steatocholestasis (Kobak et al). 2005;145:247-62
Rho signaling in TWNT-4 human hepatic stellate cells (Hi-
Proteome of H-411E (liver) cells exposed to insulin and tumor
gashi et al). 2005;145:316-22
necrosis factor-a: Analysis of proteins involved in insulin
Thea sinensis-the common tea plant (Hammerschmidt). 2005;
resistance (Solomon et al). 2005;145:275-83
145:328-9 (About the cover)
This month in J Lab Clin Med (Hammerschmidt). 2005;145: This month in J Lab Clin Med (Hammerschmidt). 2005;145:
285-8 225-7
Hepatoma; see Hepatocellular carcinoma
HIV infections ;
Hemoglobin, recombinant Nocardiosis in persons with human immunodeficiency virus in-
To publish or not to publish? (Schechter and Miller). 2005;145: fection, transplant recipients, and large, geographically de-
9-11 (Editorial) fined populations (Filice). 2005; 145:156-62
To publish or not to publish (Winslow) (Letter); (Hammer- This month in J Lab Clin Med (Hammerschmidt). 2005;145:
schmidt) (Reply). 2005;145:221-2 115-7
J Lab Clin Med
338 Subject Index June 2005
Human biologic materials Institutional review board
The importance of cultural considerations in the promotion of Searching for an efficient institutional review board review mod-
ethical research with auman biologic material (Jenkins and el: Interrelationship of trainee-investigators, funding, and ini-
Sugarman). 2005;145:1! 18-24 (Review) tial approval (Dominguez et al). 2005;145:65-71 (Review)
Human experimentation Insulin
Increased plasma anti-Xa activity and recovery of heparin from Insulin alters nuclear factor-«B and peroxisome proliferator-ac-
urine suggest absorption of orally administered unfractionated tivated receptor-y protein expression induced by glycated
heparin in human subjects (Hiebert et al). 2005;145:151-5 bovine serum albumin in vascular smooth-muscle cells (De
Role of the industry sponsor: Protection of human subjects in Oliveira et al). 2005;145:144-50
early device-application studies (Oleson). 2005;145:17-20 Proteome of H-411E (liver) cells exposed to insulin and tumor
(Review) necrosis factor-a: Analysis of proteins involved in insulin
resistance (Solomon et al). 2005;145:275-83
This month in J Lab Clin Med: Issue highlights for January 2005
(Hammerschmidt). 2005;145:1-4 (Editorial) This month in J Lab Clin Med (Hammerschmidt). 2005;145:
115-7
Hydroxymethylglutaryl-CoA reductase inhibitors
Insulin resistance
Association between reduced low density lipoprotein oxidation
Proteome of H-411E (liver) cells exposed to insulin and tumor
and inhibition of monocyte chemoattractant protein-1 produc-
necrosis factor-a: Analysis of proteins involved in insulin
tion in statin-treated subjects (Rosenson et al). 2005;145:83-7
resistance (Solomon et al). 2005;145:275-83
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
59-62
225-7
Hypertension
Intellectual property
This month in J Lab Clin Med (Hammerschmidt). 2005;145:1-4
This month in J Lab Clin Med (Hammerschmidt). 2005;145:1-4
Intercellular adhesion molecule-1
Polynitroxyl albumin inhibits inflammation and vasoocclusion in
ICAM-1; see Intercellular adhesion molecule-| transgenic sickle mice (Mahaseth et al). 2005;145:204-11
Interferon-y
Idiopathic intracranial hypertension; see Pseudotumor cerebri
Evaluation of interferon-y, interferon-y-inducing cytokines, and
IgA nephropathy; see Glomerulonephritis, IgA
interferon-y-inducible chemokines in tuberculous pleural ef-
Immunoglobulin A fusions (Okamoto et al). 2005;145:88-93
This month in J Lab Clin Med (Hammerschmidt). 2005;145:
Interferon-y-inducible protein of 10-kD; see Chemokines, CXC
225-7
Interferon-inducible T-cell a attractant; see Chemokines, CXC
Incidence
Interleukin-2 soluble receptor a
Nocardiosis in persons with human immunodeficiency virus in-
Effect of influenza vaccine on markers of inflammation lipid
fection, transplant recipients, and large, geographically de-
profile: National Heart, Lung, and Blood Institute Genetics of
fined populations (Filice). 2005;145:156-62
Lipid Lowering Drugs and Diet Network Study (Tsai et al).
This month in J Lab Clin Med (Hammerschmidt). 2005;145: 2005; 145:323-7
115-7
Interleukin-6
Industry
Effect of influenza vaccine on markers of inflammation lipid
Role of the industry sponsor: Protection of human subjects in
profile: National Heart, Lung, and Blood Institute Genetics of
early device-application studies (Oleson). 2005;145:17-20
Lipid Lowering Drugs and Diet Network Study (Tsai et al).
(Review) 2005;145:323-7
Inflammation
Interleukin-12
Effect of influenza vaccine on markers of inflammation lipid Evaluation of interferon-y, interferon-y-inducing cytokines, and
profile: National Heart, Lung, and Blood Institute Genetics of interferon-y-inducible chemokines in tuberculous pleural ef-
Lipid Lowering Drugs and Diet Network Study (Tsai et al). fusions (Okamoto et al). 2005;145:88-93
2005;145:323-7
Interleukin-18
Polynitroxy! albumin inhibits inflammation and vasoocclusion in
Evaluation of interferon-y, interferon-y-inducing cytokines, and
transgenic sickle mice (Mahaseth et al). 2005;145:204-11
interferon-y-inducible chemokines in tuberculous pleural ef-
Influenza vaccines fusions (Okamoto et al). 2005;145:88-93
Effect of influenza vaccine on markers of inflammation lipid Intestinal blood flow
profile: National Heart, Lung, and Blood Institute Genetics of Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1
” Lipid Lowering Drugs and Diet Network Study (Tsai et al). on blood pressure, intestinal blood flow, and gut oxygenation
2005; 145:323-7
in a rat model of hemorrhagic shock (Raat et al). 2005;145:
This month in J Lab Clin Med (Hammerschmidt). 2005;145: 21-32
285-8 To publish or not to publish? (Schechter and Miller). 2005;145:
Informed consent 9-11 (Editorial)
More realism about informed consent (Satin). 2005;145:292-4 To publish or not to publish (Winslow) (Letter); (Hammer-
(Editorial) schmidt) (Reply). 2005;145:221-2
Some realism about informed consent (Schneider). 2005;145: Isotretinoin
289-91 (Editorial) Chemoprevention of hepatocellular carcinoma: Use of tamoxifen
This month in J Lab Clin Med (Hammerschmidt). 2005;145: in an animal model of hepatocarcinogenesis (Di Bisceglie et
285-8 al). 2005;145:134-8